These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related]
46. Prevalence of cutaneous drug eruptions in adult Nigerians with HIV/AIDS. Salami TA; Asalu AF; Samuel SO Niger Postgrad Med J; 2010 Jun; 17(2):160-3. PubMed ID: 20539333 [TBL] [Abstract][Full Text] [Related]
47. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru. Marquiño W; Ylquimiche L; Hermenegildo Y; Palacios AM; Falconí E; Cabezas C; Arróspide N; Gutierrez S; Ruebush TK Am J Trop Med Hyg; 2005 May; 72(5):568-72. PubMed ID: 15891131 [TBL] [Abstract][Full Text] [Related]
48. Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica. East-Innis AD; Thompson DS West Indian Med J; 2009 Jun; 58(3):227-30. PubMed ID: 20043529 [TBL] [Abstract][Full Text] [Related]
49. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity. Jick H; Derby LE Pharmacotherapy; 1995; 15(4):428-32. PubMed ID: 7479194 [TBL] [Abstract][Full Text] [Related]
50. Clinical pattern of cutaneous drug eruption among children and adolescents in north India. Sharma VK; Dhar S Pediatr Dermatol; 1995 Jun; 12(2):178-83. PubMed ID: 7659648 [TBL] [Abstract][Full Text] [Related]
52. [Serious side effects of sulfadoxine/pyrimethamine as antimalarials]. Christensen PK; Loft S; Olsen VV Ugeskr Laeger; 1983 Jan; 145(4):245. PubMed ID: 6845486 [No Abstract] [Full Text] [Related]
53. Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. JAMA; 1985 Jan; 253(4):483. PubMed ID: 3881605 [No Abstract] [Full Text] [Related]
54. Treatment of toxic epidermal necrolysis and a review of six cases. Ward DJ; Krzeminska EC; Tanner NS Burns; 1990 Apr; 16(2):97-104. PubMed ID: 2140940 [TBL] [Abstract][Full Text] [Related]
55. Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Boccia R; Anné PR; Bourhis J; Brizel D; Daly C; Holloway N; Hymes S; Koukourakis M; Kozloff M; Turner M; Wasserman T Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):302-9. PubMed ID: 15337569 [TBL] [Abstract][Full Text] [Related]
56. Fansidar prophylaxis, therapy, and immune responses in rodent malaria (Plasmodium berghei). Ferraroni JJ; Speer CA J Parasitol; 1982 Aug; 68(4):609-15. PubMed ID: 6750070 [TBL] [Abstract][Full Text] [Related]
57. Surveillance for adverse drug reactions to combination antimalarial therapy with sulfadoxine-pyrimethamine plus artesunate in Peru. Cairo J; Durand S; Marquiño W; Cabezas C; Lachira A; Quintana F; Vegas W; Ruebush TK; Utz G; Bacon DJ Am J Trop Med Hyg; 2008 Jul; 79(1):42-4. PubMed ID: 18606762 [TBL] [Abstract][Full Text] [Related]
58. Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS. Navin TR; Miller KD; Satriale RF; Lobel HO Lancet; 1985 Jun; 1(8441):1332. PubMed ID: 2860516 [No Abstract] [Full Text] [Related]
60. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]